All Pharma News
Startups raised millions to in-license drugs to China. Then the model fell apart

Startups raised millions to in-license drugs to China. Then the model fell apart
Amber Tong ENDPTS
12 Mar 2024
Share Share
LianBio Announces Voluntarily Delisting from Nasdaq

LianBio Announces Voluntarily Delisting from Nasdaq
GLOBENEWSWIRE
28 Feb 2024
Share Share
LianBio lays off half of workforce as biotech winds down

LianBio lays off half of workforce as biotech winds down
James Waldron FIERCE BIOTECH
13 Feb 2024
Share Share
Nanobiotix Partner LianBio Assigns Its Development Rights for NBTXR3

Nanobiotix Partner LianBio Assigns Its Development Rights for NBTXR3
GLOBENEWSWIRE
26 Dec 2023
Share Share
LianBio Announces Departure of Chief Financial Officer

LianBio Announces Departure of Chief Financial Officer
GLOBENEWSWIRE
20 Dec 2023
Share Share
LianBio Announces Departure of Chief Executive Officer

LianBio Announces Departure of Chief Executive Officer
GLOBENEWSWIRE
19 Dec 2023
Share Share
LianBio`s Board of Directors Determines not to Pursue Proposal from Concentra

LianBio`s Board of Directors Determines not to Pursue Proposal from Concentra
GLOBENEWSWIRE
06 Dec 2023
Share Share
Concentra back with another buyout offer, this time for LianBio

Concentra back with another buyout offer, this time for LianBio
Gabrielle Masson FIERCE BIOTECH
02 Dec 2023
Share Share
LianBio Confirms Receipt of Unsolicited Proposal from Concentra Biosciences

LianBio Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
GLOBENEWSWIRE
01 Dec 2023
Share Share
LianBio Reports Third Quarter 2023 Financial Results

LianBio Reports Third Quarter 2023 Financial Results
GLOBENEWSWIRE
13 Nov 2023
Share Share